MOCS2 antibody
Principal name
MOCS2 antibody
Alternative names for MOCS2 antibody
MOCO1, MOCO1-A, Molybdenum cofactor synthesis protein 2A, Molybdenum cofactor synthesis protein 2 small subunit, Molybdopterin-synthase small subunit
Gene ID
4338 (MOCS2)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB)
Background of MOCS2 antibody
Transient overexpression lysate of molybdenum cofactor synthesis 2 (MOCS2), transcript variant 1
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP314804 | MOCS2 (transcript variant 1) |
||||
| Recombinant protein of human molybdenum cofactor synthesis 2 (MOCS2), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406129 | MOCS2 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC208485L1V | Lenti ORF particles, MOCS2 (Myc-DDK tagged) - Human molybdenum cofactor synthesis 2 (MOCS2), transcript variant 3 , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||